Back to top

pot-stocks: Archive

Sundeep Ganoria

3 Cannabis Stocks to Watch After Trump's Marijuana Rescheduling Signal

Trump's marijuana rescheduling remarks reignite cannabis optimism, putting Village Farms, Canopy Growth and High Tide in focus.

CGCNegative Net Change VFFPositive Net Change HITINegative Net Change

Sundeep Ganoria

Can Cannabis Stocks Reverse Their Prolonged Downtrend?

Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.

CRBPPositive Net Change CGCNegative Net Change TLRYPositive Net Change HRMYNegative Net Change GTBIFNegative Net Change

Sundeep Ganoria

Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release?

Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.

CGCNegative Net Change TLRYPositive Net Change ACBNegative Net Change CURLFNegative Net Change

Sundeep Ganoria

Cannabis Operator CRLBF Plans California Exit: How to Play the Stock?

Cresco plans to exit California, citing tough market dynamics, as it sharpens focus on high-margin growth markets.

TLRYPositive Net Change GTBIFNegative Net Change CRLBFNegative Net Change CURLFNegative Net Change

Sundeep Ganoria

Cannabis Stock Cresco Labs Plunges 24% YTD: Time to Sell or Hold?

CRLBF is down 24% YTD as U.S.-only exposure, falling margins and tighter regulations weigh on its cannabis business.

CGCNegative Net Change TLRYPositive Net Change ACBNegative Net Change CRLBFNegative Net Change

Sundeep Ganoria

Cannabis Operator Curaleaf Plunges 46% YTD: Time to Sell or Hold?

CURLF dives 46% YTD as domestic headwinds outweigh global growth; is it time to cash out or wait for a rebound?

CGCNegative Net Change TLRYPositive Net Change ACBNegative Net Change CURLFNegative Net Change

Sundeep Ganoria

Could the New Federal Bill Derail the U.S. Hemp Industry?

A proposed federal bill could upend the U.S. hemp market, threatening CBD and Delta-8 products now sold nationwide.

CGCNegative Net Change TLRYPositive Net Change CURLFNegative Net Change

Sundeep Ganoria

Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell?

Canopy Growth surges 39% in three months as restructuring, margin gains and debt cuts renew investor interest.

CGCNegative Net Change TLRYPositive Net Change ACBNegative Net Change VFFPositive Net Change

Sundeep Ganoria

Cannabis Operator VFF Sells Fresh Produce Unit: How to Play the Stock?

After dropping its produce business, Village Farms sharpens its cannabis focus - boosting exports, margins and market share.

CGCNegative Net Change TLRYPositive Net Change ACBNegative Net Change VFFPositive Net Change

Sundeep Ganoria

Aurora Cannabis Stock Rises 30% YTD: Time to Buy or Sell?

ACB's 30% YTD rally reflects Q3 strength, but flat EPS estimates and consumer weakness keep analysts cautious about long-term upside.

CGCNegative Net Change TLRYPositive Net Change ACBNegative Net Change

Sundeep Ganoria

Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold?

TLRY's pivot into beverages shows promise, but with falling cannabis sales and delisting risks, we recommend staying on the sidelines for now.

PMNegative Net Change JAZZNegative Net Change CRBPPositive Net Change TLRYPositive Net Change

Sundeep Ganoria

3 Unconventional Cannabis Stocks to Watch in 2025

Think cannabis investing is all hype? These three unconventional stocks could change your mind - and your portfolio - in 2025.

PMNegative Net Change JAZZNegative Net Change CRBPPositive Net Change

Sundeep Ganoria

Cardiol Therapeutics Stock: Is Cannabis Potential Priced In?

Cardiol Therapeutics shows promise with its CBD-based heart therapy, but a lack of approved drugs and a narrow pipeline raise red flags for cautious investors.

JAZZNegative Net Change KNSAPositive Net Change CRDLPositive Net Change

Sundeep Ganoria

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Not your typical cannabis play. Discover why Jazz Pharma's FDA-approved CBD drug could make it a top cannabis stock to watch in 2025.

JAZZNegative Net Change TLRYPositive Net Change

Bryan Hayes

Is Tilray Brands (TLRY) A Buy Ahead of Fiscal Q3 Earnings Announcement?

Industry headwinds still present a major challenge.

TLRYPositive Net Change

Tirthankar Chakraborty

3 Hot Cannabis Stocks That Should be on Your Watchlist

Cannabis stocks are set to be the rage on Wall Street in hopes of legalization in the US. Thus, keep an eye on stocks like Tilray (TLRY), Innovative Industrial Properties (IIPR) & GrowGeneration (GRWG).

IIPRNegative Net Change GRWGPositive Net Change TLRYPositive Net Change

Zacks Equity Research

Innovative Industrial (IIPR) Expands Maryland Base With Buyout

Innovative Industrial's (IIPR) Maryland property buyout and tie-up with a subsidiary of Harvest to help the REIT bank on solid opportunities in the company's markets and boost its top line.

PSANegative Net Change EXRPositive Net Change OUTPositive Net Change IIPRNegative Net Change

Zacks Equity Research

Innovative Industrial (IIPR) Cheers Investors With Dividend Hike

Innovative Industrial's (IIPR) nearly 6.5% sequential dividend hike reflects its tenth dividend increase since this cannabis-focused real estate company completed its initial public offering in December 2016.

EXRPositive Net Change GNLNegative Net Change IIPRNegative Net Change PINEPositive Net Change

Zacks Equity Research

Innovative Industrial (IIPR) Buys Texas Asset, Boosts Portfolio

Expansion of portfolio with the Texas property buyout and tie-up with Parallel can help Innovative Industrial Properties (IIPR) benefit from favorable trends while driving its top line.

EXRPositive Net Change GNLNegative Net Change IIPRNegative Net Change PINEPositive Net Change

Zacks Equity Research

Key Factors to Impact Innovative Industrial (IIPR) Q4 Earnings

With several states in the United States giving cannabis the green light, Innovative Industrial's (IIPR) investment in such properties is likely to have aided its Q4 performance.

AMTNegative Net Change PSANegative Net Change CUBEPositive Net Change IIPRNegative Net Change

Zacks Equity Research

Scotts Miracle-Gro (SMG) Q4 Earnings Lag Estimates, Sales Top

In Q4, Scotts Miracle-Gro (SMG) delivers growth in the U.S. Consumer and Hawthorne segments across all product categories, geographies and retail channels.

SMGPositive Net Change AEMPositive Net Change BTGPositive Net Change

Zacks Equity Research

Why You Should Add Scotts Miracle-Gro (SMG) to Your Portfolio

Upbeat prospects for the U.S. Consumer and Hawthorne segments make Scotts Miracle-Gro (SMG) an appropriate investment option now.

SMGPositive Net Change LODENegative Net Change BNTGYPositive Net Change EQXPositive Net Change

Sanghamitra Saha

Here's How to Play a Likely Biden Win

Per an ABC News/Washington Post national poll released on Oct 11, Biden has a lead over Trump by 12 percentage points nationally.

TSLANegative Net Change OCPositive Net Change VSLRPositive Net Change GOPositive Net Change EVBGPositive Net Change CGCNegative Net Change

Zacks Equity Research

What's Driving Scotts Miracle-Gro's Rally of 44% in 6 Months?

Positive outlook, strong demand in the U.S. Consumer unit and bright prospects in the Hawthorne business are major factors driving Scotts Miracle-Gro's (SMG) shares.

KGCPositive Net Change SMGPositive Net Change AUYPositive Net Change EGOPositive Net Change

Zacks Equity Research

What Makes Scotts Miracle-Gro (SMG) a Solid Pick Right Now

Strong Q3 performance and upbeat views make Scotts Miracle-Gro (SMG) an attractive investment option.

SMGPositive Net Change AUYPositive Net Change EGOPositive Net Change NAKPositive Net Change